-
Mashup Score: 0Pharmalittle: FTC suspends challenge to Amgen deal for Horizon; AstraZeneca is latest to challenge Medicare drug negotiations - 8 month(s) ago
The U.S. Federal Trade Commission suspended its challenge to Amgen’s $27.8 billion acquisition of Horizon Therapeutics.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Administrative Research Assistant in Sutton (Greater London) | The Institute of Cancer Research - 8 month(s) ago
View details and apply for this Administrative Research Assistant vacancy in Sutton (Greater London). Salary: Appointments are normally made at the starting salary, however comparable skills and experience will be considered. Future progression is based on annual performance review. Durat…
Source: jobs.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The agencies contacted 130 health systems and telehealth providers by mail to emphasize the potential HIPAA risks of using of Meta/Facebook pixel and Google Analytics tracking tools that may be
Source: www.healthcareitnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: FDA approves first gene therapy for Duchenne muscular dystrophy; states join FTC to stop Amgen deal - 10 month(s) ago
The states of California, New York, Illinois, Minnesota, Washington, and Wisconsin have joined a Federal Trade Commission lawsuit to stop Amgen from buying Horizon Therapeutics.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0FTC moves to strengthen Health Breach Notification Rule’s applicability to digital health apps - 11 month(s) ago
Regulators are increasingly leaning on the HBNR to crack down on the sharing of sensitive medical data, and the FTC is looking to strengthen its case.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs - 11 month(s) ago
A federal appeals court panel heard arguments in a case that could determine the future of a commonly used abortion pill.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1FTC widens probe into pharmacy benefit managers to include group purchasing organizations - 11 month(s) ago
The Federal Trade Commission is widening its probe into PBMs and their impact on drug pricing by looking into a pair of group purchasing organizations owned by PBMs.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0What We’re Reading: Excess Deaths in Black Communities; FTC Sues to Block Acquisition; Cancer Drug Shortages - 11 month(s) ago
Black populations suffered 1.6 million excess deaths in the past 20 years, new studies find; the Federal Trade Commission (FTC) sues to block Amgen from acquiring Horizon Therapeutics, citing 2 drugs that have no competition; cancer drug shortages are approaching an all-time high.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 4Pharmalittle: FTC suit over Amgen spotlights 'bundling' deals with insurers; FDA staff says Pfizer RSV vaccine is effective - 11 month(s) ago
The FTC’s suit to block Amgen from acquiring Horizon Therapeutics cast a spotlight on a practice known as bundling.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers - 11 month(s) ago
The FTC’s move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers — and in particular, a practice known as bundling.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
Pharmalot.. Pharmalittle.. Good Morning: FTC suspends challenge to Amgen deal for Horizon; AstraZeneca is latest to challenge Medicare drug negotiations & More news. https://t.co/tBSuCcoLDj #pharma #obesity #weightloss #Medicare #FTC #opioids $BAYRY $AZN $CVS $RAD $NVO $LLY $AMGN